JP Stock MarketDetailed Quotes

4883 Modalis Therapeutics

Watchlist
  • 132
  • -14-9.59%
20min DelayMarket Closed Nov 1 15:00 JST
7.79BMarket Cap-1708P/E (Static)

Modalis Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Modalis Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Aug 7, 20232023/Q20.000 / 0.000--
Feb 13, 20232022/Q40.000 / 800.000M--
Nov 7, 20222022/Q30.000 / 0.000--
Aug 5, 20222022/Q20.000 / 0.000--
May 9, 20222022/Q140.000M / 0.000--
DatePeriodRevenue/EstimateEarnings Call
Aug 7, 20232023/Q20.000 / 0.000--
Feb 13, 20232022/Q40.000 / 800.000M--
Nov 7, 20222022/Q30.000 / 0.000--
Aug 5, 20222022/Q20.000 / 0.000--
May 9, 20222022/Q140.000M / 0.000--

Unlock Free Earnings Estimates

Modalis Therapeutics Earnings Reports

  • Modalis Therapeutics: Confirmatory letter.

    Aug 13 01:58 ET

  • Modalis Therapeutics: Half Year Report - Term 9 (2024/01/01 - 2024/12/31)

    Aug 13 01:58 ET

  • Modalis Therapeutics: Second quarter financial results presentation materials for December 2024 fiscal year.

    Aug 7 02:30 ET

  • Modalis Therapeutics: Financial results announcement for Q2 2024 (interim period) based on Japanese accounting standards (consolidated)

    Aug 7 02:30 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg

    No Data